Low-dose physiological growth hormone in patients with HIV and abdominal fat accumulation: a randomized controlled trial
about
HIV infection and cardiovascular diseaseThe Role of the Growth Hormone/Insulin-Like Growth Factor System in Visceral Adiposity.Safety and metabolic effects of tesamorelin, a growth hormone-releasing factor analogue, in patients with type 2 diabetes: A randomized, placebo-controlled trial.Effects of switching from lopinavir/ritonavir to atazanavir/ritonavir on muscle glucose uptake and visceral fat in HIV-infected patients.Relationship of peak growth hormone to cardiovascular parameters, waist circumference, lipids and glucose in HIV-infected patients and healthy adults.HIV-associated lipodystrophy: a review from a Brazilian perspectiveUpdate on human health concerns of recombinant bovine somatotropin use in dairy cows.Effects of a growth hormone-releasing hormone analog on endogenous GH pulsatility and insulin sensitivity in healthy men.Reduction in visceral adiposity is associated with an improved metabolic profile in HIV-infected patients receiving tesamorelin.Pathogenesis and treatment of HIV infection: the cellular, the immune system and the neuroendocrine systems perspective.Effects of growth hormone-releasing hormone on visceral fat, metabolic, and cardiovascular indices in human studies.Lipodystrophy: pathophysiology and advances in treatmentEffect of tesamorelin on visceral fat and liver fat in HIV-infected patients with abdominal fat accumulation: a randomized clinical trialEffects of low-dose growth hormone withdrawal in patients with HIV.Insulin-like growth factors and related proteins in plasma and cerebrospinal fluids of HIV-positive individuals.Growth hormone and tesamorelin in the management of HIV-associated lipodystrophyManagement of the metabolic effects of HIV and HIV drugs.Leptin in relation to the lipodystrophy-associated metabolic syndromeEffects of growth hormone withdrawal in obese premenopausal womenFat Matters: Understanding the Role of Adipose Tissue in Health in HIV InfectionA pilot study of telmisartan for visceral adiposity in HIV infection: the metabolic abnormalities, telmisartan, and HIV infection (MATH) trial.Benefits of leptin therapy in HIV patients.Effects of statin therapy on coronary artery plaque volume and high-risk plaque morphology in HIV-infected patients with subclinical atherosclerosis: a randomised, double-blind, placebo-controlled trial.Low and Normal IGF-1 Levels in Patients with Chronic Medical Disorders (CMD) is Independent of Anterior Pituitary Hormone Deficiencies: Implications for Treating IGF-1 Abnormal Deficiencies with CMDPathogenesis and treatment of HIV lipohypertrophyEffect of Recombinant Human Growth Hormone and Rosiglitazone for HIV-Associated Abdominal Fat Accumulation on Adiponectin and other Markers of InflammationTesamorelin: a review of its use in the management of HIV-associated lipodystrophy.Management of fat accumulation in patients with HIV infection.The GH/IGF-1 axis in obesity: pathophysiology and therapeutic considerations.An update on the pharmacological strategies in the treatment of HIV-1-associated adipose redistribution syndromes.Recombinant Human Growth Hormone: HIV-Related Lipodystrophy.Adult growth hormone deficiency treatment with a combination of growth hormone and insulin-like growth factor-1 resulting in elevated sustainable insulin-like growth factor-1 and insulin-like growth factor binding protein 3 plasma levels: a case repWhither recombinant human leptin treatment for HIV-associated lipoatrophy and the metabolic syndrome?Low-dose growth hormone for 40 weeks induces HIV-1-specific T cell responses in patients on effective combination anti-retroviral therapy.Effects of recombinant human growth hormone administration on cardiovascular risk factors in obese children with relative growth hormone deficiency.
P2860
Q27008915-9FB0688E-F30A-418F-A9E4-4A070694C849Q33602919-35A285F0-D004-4A8F-A451-6B9E7B1D9D37Q33803331-1E83C917-8144-4589-974D-545A4222E636Q33918414-FF1E5C99-4E75-4BAC-9A12-E7937BAD05DFQ33926905-B2454B2E-59EA-4A5D-9C28-21494B5A782DQ33939681-E205224B-105F-4BD2-8A1F-8C2F35A8C177Q34411789-082833E1-A4E3-430A-96CD-CB9B395E47ABQ34571826-1BF635FB-5EAD-4A04-915E-DFD8AE7CC798Q34637395-070D444F-AC8B-46EA-B28B-96037A5F9A03Q34650866-4065FB7A-A065-4C72-9504-343F56D96452Q35072510-61B5E3AD-248C-4508-9455-7F0197718C62Q35148915-DA1ECC68-9569-476D-916A-337F514A916FQ35186541-214BCF3D-0FF6-4989-8C0B-696525ED761EQ35482271-C2355A81-5231-432D-A2D2-5B7ABF13B98BQ35530481-49275082-9DBE-4DBA-AA32-42197EC0E80FQ35557342-10E3176F-54DD-4AC5-8C37-E85EED00779BQ36021411-74DE297A-FF39-457E-AAD4-65765F9A5150Q36049195-F23BC287-5054-4A2A-A165-2C60A75824DDQ36652243-D18D105F-3310-490F-BFD4-2E711A656CADQ36654972-FA9A2B3B-03DB-4294-9DC6-E457C76EB978Q36684708-837509E5-0AA4-4C39-B1A4-91800BD97017Q36700922-2CB4A0BF-8216-4414-AAC4-0B6661C1D43FQ36765204-85FD04BA-AFB3-4E9B-8794-8A10CA0E05C3Q36784361-CB589799-62D4-4318-9414-68419C2A56C3Q36900984-19C76861-B5FF-4AFE-BC81-9137F55939CAQ37085712-C8D6ED50-0603-4CDB-A98C-396D9D60D9C8Q37888672-FC45D132-9092-45C5-8EBE-B84EF028E3ABQ37899071-EC8E83AE-AB9C-4444-9529-BE34EAA1F952Q38097351-795C351D-2FF9-48EA-9ADB-A372E3DE9669Q38220651-85608F6B-936E-465C-AE70-4CCD01E41CE7Q40864476-F5A60FA6-6B0D-4136-8114-67FD9F972AA4Q42409944-F4989B90-7BC2-40FE-A9A6-0E3FAEEBA271Q43066028-DCA2D199-D0F0-4CBC-96B6-CEEB281A179CQ50899394-ED275056-0E37-4841-A23A-C33E1AEB2362Q53698784-47F5037A-350D-41E1-BBEC-20D3A6973D24
P2860
Low-dose physiological growth hormone in patients with HIV and abdominal fat accumulation: a randomized controlled trial
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Low-dose physiological growth ...... a randomized controlled trial
@en
type
label
Low-dose physiological growth ...... a randomized controlled trial
@en
prefLabel
Low-dose physiological growth ...... a randomized controlled trial
@en
P2093
P2860
P356
P1476
Low-dose physiological growth ...... a randomized controlled trial
@en
P2093
Bridget Canavan
Greg Beltrani
James Liebau
Linda Hemphill
Polyxeni Koutkia
Steven Grinspoon
Sung Min You
P2860
P304
P356
10.1001/JAMA.300.5.509
P407
P577
2008-08-01T00:00:00Z